Antonio Boza-Serrano
Antonio Boza-Serrano
Juan de la Cierva, Universidad de Sevilla
Verified email at
Cited by
Cited by
Microglia in neurological diseases: a road map to brain-disease dependent-inflammatory response
S Bachiller, I Jiménez-Ferrer, A Paulus, Y Yang, M Swanberg, ...
Frontiers in cellular neuroscience 12, 488, 2018
Microglia-secreted galectin-3 acts as a toll-like receptor 4 ligand and contributes to microglial activation
MA Burguillos, M Svensson, T Schulte, A Boza-Serrano, ...
Cell reports 10 (9), 1626-1638, 2015
Targeting neuroinflammation to treat Alzheimer’s disease
A Ardura-Fabregat, E Boddeke, A Boza-Serrano, S Brioschi, ...
CNS drugs 31, 1057-1082, 2017
Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease
A Boza-Serrano, R Ruiz, R Sanchez-Varo, J García-Revilla, Y Yang, ...
Acta neuropathologica 138, 251-273, 2019
Inflammation leads to distinct populations of extracellular vesicles from microglia
Y Yang, A Boza-Serrano, CJR Dunning, BH Clausen, KL Lambertsen, ...
Journal of neuroinflammation 15, 1-19, 2018
Forced treadmill exercise can induce stress and increase neuronal damage in a mouse model of global cerebral ischemia
M Svensson, P Rosvall, A Boza-Serrano, E Andersson, J Lexell, ...
Neurobiology of stress 5, 8-18, 2016
Alpha-synuclein expression in the oligodendrocyte lineage: an in vitro and in vivo study using rodent and human models
M Djelloul, S Holmqvist, A Boza-Serrano, C Azevedo, MS Yeung, ...
Stem cell reports 5 (2), 174-184, 2015
Innate immune alterations are elicited in microglial cells before plaque deposition in the Alzheimer’s disease mouse model 5xFAD
A Boza-Serrano, Y Yang, A Paulus, T Deierborg
Scientific reports 8 (1), 1550, 2018
The role of Galectin-3 in α-synuclein-induced microglial activation
A Boza-Serrano, JF Reyes, NL Rey, H Leffler, L Bousset, U Nilsson, ...
Acta neuropathologica communications 2 (1), 1-14, 2014
Hyperinflammation and fibrosis in severe COVID-19 patients: galectin-3, a target molecule to consider
J Garcia-Revilla, T Deierborg, JL Venero, A Boza-Serrano
Frontiers in Immunology 11, 2069, 2020
APOE in the bullseye of neurodegenerative diseases: Impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
R Fernández-Calle, SC Konings, J Frontiñán-Rubio, J García-Revilla, ...
Molecular Neurodegeneration 17 (1), 62, 2022
Fumarate decreases edema volume and improves functional outcome after experimental stroke
BH Clausen, L Lundberg, M Yli-Karjanmaa, NA Martin, M Svensson, ...
Experimental neurology 295, 144-154, 2017
Divergent effects of metformin on an inflammatory model of Parkinson’s disease
K Tayara, AM Espinosa-Oliva, I García-Domínguez, AA Ismaiel, ...
Frontiers in cellular neuroscience 12, 440, 2018
FGF family members differentially regulate maturation and proliferation of stem cell-derived astrocytes
E Savchenko, GN Teku, A Boza-Serrano, K Russ, M Berns, T Deierborg, ...
Scientific reports 9 (1), 9610, 2019
Galectin-3 causes enteric neuronal loss in mice after left sided permanent middle cerebral artery occlusion, a model of stroke
X Cheng, A Boza-Serrano, MF Turesson, T Deierborg, E Ekblad, U Voss
Scientific Reports 6 (1), 32893, 2016
Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration
J García-Revilla, A Boza-Serrano, AM Espinosa-Oliva, MS Soto, ...
Cell Death & Disease 13 (7), 628, 2022
Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study
KT Kovacs, SR Kalluri, A Boza-Serrano, T Deierborg, T Csepany, M Simo, ...
Multiple Sclerosis Journal 22 (9), 1192-1201, 2016
Interleukin-6 is increased in plasma and cerebrospinal fluid of community-dwelling domestic dogs with acute ischaemic stroke
H Gredal, BB Thomsen, A Boza-Serrano, L Garosi, C Rusbridge, ...
Neuroreport 28 (3), 134, 2017
Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer’s disease
A Boza-Serrano, A Vrillon, K Minta, A Paulus, L Camprubí-Ferrer, ...
Acta Neuropathologica 144 (5), 843-859, 2022
The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease
I Jimenez-Ferrer, F Bäckström, A Duenas-Rey, M Jewett, A Boza-Serrano, ...
Brain, Behavior, and Immunity 91, 369-382, 2021
The system can't perform the operation now. Try again later.
Articles 1–20